Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma-Reference-Cited by-同舟云学术

Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma

Published:2022-01-14 Issue: Volume:8 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Osei-Bordom Daniel C.,Sachdeva Gagandeep,Christou Niki

Abstract

Pancreatic ductal adenocarcinomas (PDAC) represent one of the deadliest cancers worldwide. Survival is still low due to diagnosis at an advanced stage and resistance to treatment. Herein, we review the main types of liquid biopsy able to help in both prognosis and adaptation of treatments.

Publisher

Frontiers Media SA

Subject

General Medicine

Reference128 articles.

1. Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective;Postel;Expert Rev Mol Diagn.,2018

2. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing;Gerlinger;N Engl J Med.,2012

3. Liquid biopsy: unlocking the potentials of cell-free DNA;Chu;Virchows Arch.,2017

4. Detection of circulating tumor DNA in early- and late-stage human malignancies;Bettegowda;Sci Transl Med.,2014

5. Liquid biopsy: monitoring cancer-genetics in the blood;Crowley;Nat Rev Clin Oncol.,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in Pancreatic Ductal Adenocarcinoma;Cells;2023-12-19

2. Gadolinium-Doped Carbon Nanodots as Potential Anticancer Tools for Multimodal Image-Guided Photothermal Therapy and Tumor Monitoring;ACS Applied Nano Materials;2023-09-05

3. Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer;Exploration of Targeted Anti-tumor Therapy;2023-02-28